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1. Introduction
The protozoan parasite Theileria parva is transmitted by
Rhipicephalus ticks and causes an often fatal lymphopro-
liferative disease of cattle known as East Coast fever (ECF).
In keeping with the distribution of its principal vectors,
Rhipicephalus appendiculatus and R. zambeziensis, the
disease is prevalent in eastern, central and southern Africa
(Lawrence et al., 1994), where an estimated 24 million
cattle are at risk of infection. Economic losses due to ECF
are substantial, as evidenced by a 1989 analysis that placed
them at US$168 (Mukhebi et al., 1992). Efforts to control
ECF are largely based on the use of acaricides to prevent
infestation with infected ticks, but this approach is
increasingly being compromised by the emergence of
acaricide resistance in the vector tick populations.
Although drugs are available to treat the disease, these
are expensive and require an early diagnosis to be
effective. It is also possible to immunise cattle against
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A B S T R A C T
The tick-borne protozoan parasite Theileria parva causes East Coast fever (ECF), a severe
lymphoproliferative disease of cattle that is a major constraint to the improvement of
livestock in eastern, central and southern Africa. Studies in cattle experimentally infected
with T. parva have shown that the protective cytotoxic T lymphocyte (CTL) response is
tightly focused, with individual animals recognizing only one or two dominant antigens,
the identity of which varies with MHC class I phenotype. It is well known that cross-
protection between T. parva stocks is limited, but precise evaluation of genetic diversity in
ﬁeld populations of the parasite has been hampered by a lack of molecular markers
spanning the genome. A recently described panel of satellite markers has provided
evidence for substantial genotypic diversity and recombination but does not provide cover
for large segments of the genome. To address this deﬁciency, we undertook to identify
additional polymorphic markers covering these regions and we report herein 42 newly
identiﬁed PCR-RFLP markers distributed across the 4 T. parva chromosomes, as well as 19
new satellite markers for chromosomes 1 and 2. This brings the total number of available
polymorphic markers to 141 for the 8.5Mb genome. We have used these markers to
characterise existing parasite stabilates and have also shown that passage of the parasite
through naı¨ve cattle and ticks can lead to substantial changes of parasite populations in
resulting stabilates. These markers have also been used to show that passage of mixed
parasites through an immunised calf results in the removal of the immunising genotype
from the parasite population produced by ticks fed on this animal.
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T. parva by inoculation with live parasites in combination
with long acting formulations of oxytetracycline. This so-
called infection and treatment method (Radley et al.,
1975a,b) is effective, but its uptake has been hampered by
cold chain difﬁculties and concerns that vaccine strains
might establish in resident tick populations and mix with
local parasite genotypes (Oura et al., 2007).
The parasite has a complex life cycle (Mehlhorn and
Schein, 1984), involving obligate developmental stages in
mammalian and vector hosts. Cattle become infected by
inoculation of sporozoite forms in the tick saliva. These
invade lymphocytes and differentiate to multinucleate
schizonts, which drive the cell into a state of continuous
proliferation and divide with it, ensuring transmission of
infection to each daughter cell. In a proportion of infected
cells, schizonts undergo further differentiation to uni-
nucleatemerozoites; these are released from the dying cell
and invade erythrocytes, where they develop into tick-
infective piroplasm forms. Upon ingestion by a feeding
tick, these are released into the gut lumen and give rise to
macro and micro gametes, which undergo syngamy to
form diploid zygotes. After invading gut epithelial cells,
zygotes undergo reduction division to yield kinete forms,
which access the hemocoel and migrate to the salivary
gland, where they invade cells of type III acini. The parasite
then undergoes a process of sporogony to produce cattle-
infective sporozoites. The parasite therefore adopts a
strategy whereby expansion is accomplished through
asexual division, with an exponential phase in the case
of the schizont, while genetic exchange is accommodated
through a sexual phase in the tick (Neitz, 1957).
Early observations of limited cross-protection among
ﬁeld isolates of T. parva prompted a strong interest in the
diversity of the parasite. This led to the generation of
monoclonal antibodies that could distinguish between
different parasite isolates (Minami et al., 1983; Conrad
et al., 1989). The advent of DNA-based technologies gave
rise to the development of a series of new markers that
could distinguish multiple genotypes simultaneously. The
ﬁrst of these were Southern blot-based and used combina-
tions of restriction enzymes and probes for the small
subunit ribosomal RNA gene as well as probes for multi-
copy genes from the TpR and sub telomeric loci (Bishop
et al., 1993). These markers showed extensive polymorph-
ism between isolates but the results of mixed infections
were more difﬁcult to interpret. PCR-RFLPs of the 18S
ribosomal RNA locus, Polymorphic Immunodominant
Molecule (PIM) PCR amplicon size polymorphisms and
PIM sequence analysis were also used to distinguish
different isolates and stocks (Bazarusanga et al., 2007;
Geysen et al., 2004). However, the availability of the T.
parva genome allowed the identiﬁcation of satellite
sequences comprising multiple nucleotide repeats, which,
because of varying numbers of repeats, give rise to alleles
with distinct PCR amplicon sizes. Satellite markers have
provided insights into the genetic relationship between T.
parva populations (Oura et al., 2003; Katzer et al., 2006)
and the population dynamics and sub-structuring of ﬁeld
isolates (Oura et al., 2005; Odongo et al., 2006). They have
also been applied to elucidate the impact of immune
selection on the parasite (Katzer et al., 2007) and the risks
associated with the infection and treatment method (Oura
et al., 2004, 2007). At a more practical level, the source of a
recent outbreak of ECF on the Comoros Islands was traced
to an infection and treatment vaccine used in cattle
exported from Tanzania using microsatellite proﬁling (De
Deken et al., 2007).
Although many polymorphic markers now exist for the
distinction of different T. parva genotypes, large regions of
its genome remain for which no markers are available.
Effective evaluation of recombination rates and genotypic
variation in response to selection pressure requires a
genome-wide set of markers with good coverage. We
therefore undertook to develop additional satellite and
PCR-RFLP markers to get a better genome-wide coverage.
2. Materials and methods
2.1. Parasite material
The study focused on the Marikebuni stock of T. parva,
which was initially isolated in 1981 in the Kiliﬁ District in
Kenya (Minami et al., 1983). It underwent three cattle–tick
passages at the International Livestock Research Institute
(ILRI) in Nairobi to yield ILRI St3014 (Morzaria et al., 1995).
This stabilate was passaged again at the National
Veterinary Research Centre, NVRC, in Kenya and infected
ticks were sent to the Centre for Tropical Veterinary
Medicine, University of Edinburgh. These were used to
generate stabilate CTVM St70, which has since been
passaged twice to generate stabilates CTVM St72 and
CTVM St96. The history of the T. parva Muguga stabilate
CTVM-ST80 is less well deﬁned. This isolate was main-
tained for many years by serial cattle–tick passage and
underwent several further cattle–tick passages after
importation into the UK.
2.2. Animal immunisation, challenge and stabilate
production
A Friesian calf was infected by subcutaneous inocula-
tion with 1 107 autologous cells infected with the 72-01
genotype of T. parva Marikebuni (see below). The animal
showed only mild clinical signs and recovered without
treatment. The immune status of the calf was conﬁrmed by
detection of in vitroMHC-restricted CTL activity against the
immunising cell line as described by Goddeeris and
Morrison (1988). The animal was challenged two months
after the initial infection with a lethal dose of the parent
stabilate CTVM St72 by subcutaneous inoculation above
the right prescapular lymph node. Progress of infection
was followed by monitoring rectal temperature and
examining lymph node biopsy and blood smears for the
presence of schizonts and piroplasms respectively. Unfed
nymphal R. appendiculatus ticks were applied to the ears of
the calf from day 10 of challenge to allow passage of the
break-through infection and production of a daughter
stabilate. The level of infection in the resulting tick batch
was assessed by examination of salivary glands from a
representative sample as described byWalker et al. (1979)
and stabilate CTVM St105 was prepared from it as
described by Brown (1987).
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2.3. Generation of parasite clones and lysis for PCR
Parasite clones for genotyping were generated by
limiting dilution cloning of PBMCs infected in vitro with
T. parva sporozoite stabilates or lymph node aspirates
obtained from an infected animal as described by Rocchi
et al. (2008). Parasite clones were grown in 96 well plates,
harvested and lysed, by incubation for 10 h at 56 8C in
culture medium containing 50mg/ml Proteinase K. PCR
reactions were conducted directly on the lysates after
heating to 90 8C for 10min to inactivate Proteinase K.
2.4. Polymorphic markers and genotyping
(i) PCR-RFLPs: Comparative analysis of the genomic
sequences of T. annulata and T. parva (http://
www.sanger.ac.uk and http://www.tigr.org respec-
tively) was undertaken to identify genes that are
polymorphic between the two species. Polymorphic
coding regions that differed in size between the
species were selected and primer pairs ﬂanking the
most variable segments were designed to amplify
products ranging from 600 bp to 1800 bp. PCR
amplicons generated from T. parva Muguga and
Marikebuni clones using these primers were digested
with a panel of 10 frequent cutting restriction
enzymes (AluI, DpnII, HaeIII, HhaI, HinfI, MseI, MspI,
RsaI, TaqI and Tsp509I) to identify RFLPs. Details of the
polymorphic PCR-RFLP markers are shown in Table 1.
(ii) Satellite markers: The satellite markers ms1–ms11,
MS1–MS46, MS221a, MS221b, MS312, MS717 and
MS817 have been published previously by Oura et al.
(2003) and markers MS47–MS59 have been described
by Katzer et al. (2006). The repeat ﬁnder program
(Benson, 1999) was used as described by Oura et al.
(2003) to identify 35 additional satellite loci on
chromosomes 1 and 2 for testing.
(iii) Size polymorphisms: In addition to the 4 previously
described genes that show PCR size polymorphisms
among T. parva isolates (Katzer et al., 2006), one new
Table 1
PCR-RFLP marker loci identiﬁed in this studya.
Marker Name Forward Primer Reverse Primer Restriction
Enzyme
Chromosome No. Position Amplicon
Size
PCR-RFLP 01 acagggatgattctggtaattttt tggktggcataagtamtctgtgat RsaI 1 31359 698
PCR-RFLP 02 amcgcaraatatyaaaacagaact tttttgacctacttaaatcatttgaca RsaI 1 83497 928
PCR-RFLP 03 ccakgagaaccttaacactgmctc agtcaagtttcrtcttcgtttcct MspI 1 224219 682
PCR-RFLP 04 ttgttaataccacsccaattatca aggktcyaaatactttcccaaaa TaqI 1 340696 694
PCR-RFLP 05 ygacgaagataatatggayatgga ctccatacagtgctctcgttacat RsaI 1 449608 1555
PCR-RFLP 06 cacaaggagagttatttgcgtct tcctyttcatcatcttctcraaca TaqI 1 562140 642
PCR-RFLP 07 attgacgttctcaaaattggtgat tccatttttgaagccatttttatt HinfI 1 1254876 625
PCR-RFLP 08 tgttctttttatttggactcttttcc ttggtcttctgctgtgtaagaagt HinfI 1 2040407 1564
PCR-RFLP 09 gataagttgttacgcacatgggtt atttggatcgctaactagtctgc RsaI 1 2180754 923
PCR-RFLP 10 tacttggtgcaatttctagtctcg ggcgagttgtggtaaatctca RsaI 1 2333508 1435
PCR-RFLP 11 accgggtttcagaaagtttttaat gcgaggaaattgatgagaagtagt TaqI 1 2430398 1138
PCR-RFLP 12 ctttgagaaatggctcaatgagta tgcagaggagagtgttaggatara RsaI 2 145250 1202
PCR-RFLP 13 ctaggagttaacccaggaacmag ctgatttggacttcgattcytttt TaqI 2 246693 1644
PCR-RFLP 14 ttcgcaaatttaccaaagttttta tcatccaagggttaattttcctaa MspI 2 328448 1566
PCR-RFLP 15 gtgacacatttaaccccaactatg cgtgtttaacctccatcctcttta MspI 2 610294 992
PCR-RFLP 16 ttggaccatggatttaaagagttt gataaattcaagcaaatcaaccaa MseI 2 663512 848
PCR-RFLP 17 ggtaaacctttaggtgtgtttgga tgccaaataatcctccagtagtag AluI 2 712657 1021
PCR-RFLP 18 gagagtgattttggagaaggctac gactcaaccttcttcgctactctc MspI 2 712864 1715
PCR-RFLP 19 gaaaaatgccgaaaaataaagg atcgaaatccgactcctcttg MseI 2 1541106 695
PCR-RFLP 20 ttcattgttaccaccaaatcttc cgacactttccacatcgttacata HaeIII 2 1563675 1224
PCR-RFLP 21 ggatatgataaagattggtataaatgg tcacagttaaatcaacagctgctac TaqI 2 1740543 742
PCR-RFLP 22 taaaccacaaggagctcttcctac aacgacgccttaaactttctatac HinfI 2 1760832 1401
PCR-RFLP 23 gaayggattwagatttgatgtggt atttmccagattccattraataaa HhaI 2 1797638 847
PCR-RFLP 24 tctgaacgacttgcagtatgacta gactccaacacaacgaattca HhaI 3 83833 695
PCR-RFLP 25 ggtatttaagggtagaattggagg tttccataaaggatcaatattctcaa MseI 3 157770 781
PCR-RFLP 26 ttctgatcccctgatacaattttt ttatgttaccgcaatcaccaatag HinfI 3 237629 1426
PCR-RFLP 27 tgaagcctgtcaagttgcttta tgcgttacatacacttcccttg AluI 3 426084 1783
PCR-RFLP 28 aagaacactcagttatgaaggctgt ccctcatcttaccactcaatttct HaeIII 3 451885 841
PCR-RFLP 29 ccagctgtatactcacttgttgct aacttgttttcctttggcttagg AluI 3 741856 968
PCR-RFLP 30 acggtttatgacaagtctgtacca tcgaacgagtgttttaactttttg RsaI 3 841803 1198
PCR-RFLP 31 tgagttatttgaggaaggatttgag ttttaaagagtcccaagtgttcaa HhaI 3 842942 766
PCR-RFLP 32 cacgtatgtatcccaagtatccac gaggatttgagaacccagttacc MseI 3 871672 1100
PCR-RFLP 33 tgcttaaaggctcagttatcacaa acaaattcgggtatgtttttgaa RsaI 3 1051310 973
PCR-RFLP 34 gaaaaactgctcaaactccgttat aaagtactcgtggtctggagtctg AluI 3 1054808 1119
PCR-RFLP 35 atctcaaatggctttgctaaactt gcaaataatattgcagataccagaa MseI 3 1761447 908
PCR-RFLP 36 tatatacacttcckgtwrtcggta gttcatcgtttttcccataaaca MseI 3 1843437 1469
PCR-RFLP 37 ttcatattattcggatctgtgaga tctccgtcacatactacttgttca HaeIII 4 10450 1555
PCR-RFLP 38 cagtctcaacaattgggacagata gtaacttctccttcatttccttgg RsaI 4 265377 1123
PCR-RFLP 39 tccataggtattctcgaaggtct gtgttcctatctcaccctccaac MseI 4 327090 777
PCR-RFLP 40 gacgctagactacgatgaaatgaa gtgcactctcaaacgcctaakmat Tsp509I 4 787561 630
PCR-RFLP 41 gggaacacaaaccaagcaag atctgcctcagtgccttcat AluI 4 869417 922
PCR-RFLP 42 cgttgtaggcttaatgatgaactt catcattgattttagcggtgaat RsaI 4 1124923 1142
a The amplicon sizes shown are those found in the T. parva Muguga clone 3308 (http://www.tigr.org).
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marker, TP02-0895, was identiﬁed on chromosome 2
with size variants detectable by PCR (forward primer
gcctgtcaagagtaccttaatgcc, reverse primer gaccgcttggc-
tgacctggacc).
(iv) PCR conditions and genotyping: PCR conditions used in
the study were essentially as described by Oura et al.
(2003), except that the number of cycleswas increased
to 40, Bioline (UK) taq polymerase was used and a
custom made 10 PCR buffer (45mM Tris–HCl (pH
8.8), 11mM (NH4)2SO4, 4.5mM MgCl2, 0.113mg/ml
BSA, 4.4mM EDTA, 1.0mM each of dATP, dCTP, dGTP
and dTTP) was purchased from ABgene (UK). PCR
products were separated on 2% Metasieve agarose
(Flowgen, UK), visualised with ethidium bromide and
photographed using a UV light box (BioRad, UK).
3. Results
3.1. Genetic tools to study T. parva
Comparison of the T. annulata and T. parva genomes led
to the identiﬁcation of 105 open reading frames that
exhibited sequence variation or gaps in the sequence
alignment and these were used to design T. parva-speciﬁc
primers ﬂanking the polymorphic regions. Digestion of PCR
products, obtained from T. parva Muguga and Marikebuni
clones with these primers, with a panel of 10 restriction
enzymes led to the identiﬁcation of 42 PCR-RFLPs, 3 of
which are shown in Fig. 1. A list of all PCR-RFLPS, along
with their primer sequences, relevant restriction enzyme
and location in the T. parva genome are shown in Table 1.
Large sections of chromosomes 1 and 2 were devoid of
satellite markers and these regions were therefore re-
examined using the repeat ﬁnder program (Benson, 1999)
in an attempt to identify moremarkers in those regions. As
a result, 36 further primer pairs were designed and tested
with DNA from T. parva Muguga and Marikebuni clones
and 19 of thesemarkerswere found to be polymorphic, 3 of
which are shown in Fig. 1. The names, primer sequences
and Muguga amplicon sizes of these polymorphic satellite
markers are shown in Table 2. An illustration of the
locations of all new and previously identiﬁed satellite
markers and newly identiﬁed PCR-RFLP markers are
shown in Fig. 2. The ﬁgure shows the location of all 94
polymorphic satellite markers, 42 PCR-RFLPs and the 5
genes which exhibit amplicon size polymorphisms. Of
Fig. 1. Examples of polymorphic markers identiﬁed in this study. (A) PCR-RFLP markers with corresponding restriction enzyme. (B) Newly identiﬁed
satellite markers. (C) TP02-0895 a newly discovered gene with amplicon size polymorphism. Lane 1, Muguga clone 273; lane 2, Marikebuni clone 3219.
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these markers, 43, 34, 35 and 29 markers locate on
chromosome 1, 2, 3 and 4, respectively. Of the 29 markers
on chromosome 4, 12 are tightly clustered into two groups,
separated by a stretch of over 772 kb that lacks any
polymorphic satellite markers. This stretch contains only 2
polymorphic PCR-RFLP markers, leaving chromosome 4
with the largest stretch forwhich polymorphicmarkers are
unavailable.
Table 2
New satellite marker loci identiﬁed in this studya.
Marker Name Forward Primer Reverse Primer Chromosome No. Position Amplicon Size
MS60 aatctgagggtcaaaggatt tcaatcaacatgttatcagga 1 1565 352
MS61 gaagagggtactgaagctga aggatcagtagctggagttg 1 392663 248
MS62 gcaaaatcgaactaccacat cgctctagcctctgtaacac 1 599307 271
MS63 tcattccatcggatctttat tggtaaaacttcgtaaaaagg 1 655871 263
MS64 acatccttaggcacaacatc gctgcctcatgtacaggtat 1 661710 230
MS65 tgctcaattcccaatacaa tccatttccttaaccacatc 1 829293 251
MS66 ctaccactatcaccggtagc catcagcgttacttgcatc 1 1502024 266
MS67 ctcgtttagaaaagccagaa gtctctttatcagcagcttca 1 1676770 245
MS68 tcacatcgggtaacaagaa tatttatcgaccccaaactg 1 1919116 469
MS69 atgtgtacagcaatcaacga catctgaagactcctccaaa 1 1977213 245
MS70 actcatttgcaccgtatctt aactctggaatctcaaccaa 1 2420234 227
MS71 aggtggttaggaccattagg gttgttgattcagaggttcc 2 1623 252
MS72 ttcacaatgaattctgagga aaatttcattgcttgatttga 2 184360 230
MS73 tccttgtggttcaagtaaaac caaaacctcacttcaccttt 2 906540 257
MS74 gactctggaggggaaaga gtgttaaccacgggaaaag 2 1070539 246
MS75 ccaccccgtctactatatca ttcacacaacgcttcttaaa 2 1278718 244
MS76 ggtgtgcacttaagcagttt tgaaggacttttcacacaaat 2 1378981 253
MS77 ggtaaccaacaaccacattt tgcttatgaactcaatcatctc 2 1555168 270
MS78 caaccaatctactcccaact tggatattccaatcgattattag 2 1739970 361
a The amplicon sizes shown are those found in the T. parva Muguga clone 3308 (http://www.tigr.org).
Fig. 2. Graphical illustration of the locations of polymorphic markers in the T. parva genome. Chromosomes 1–4 are denoted by I–IV. Genes with amplicon
size polymorphism and satellitemarker loci are shown on the left hand side of each chromosomes, while PCR-RFLP locations are shown on the right. Sizes of
individual chromosomes are identiﬁed below.
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3.2. Parasite population structure changes during
cattle–tick passage
PCR analysis of DNA extracted from T. parvaMarikebuni
stabilates derived from four serial cattle–tick passages
(ILRI St3014–CTVM St70–CTVM St72–CTVM St96) with a
panel of satellitemarkers revealed that individual passages
can lead to marked changes in population structure.
Representative results using the MS14 satellite marker are
illustrated in Fig. 3 and show that, while ILRI 3014 is
dominated by one allele of this marker, its passage to
CTVM 70 was associated with the emergence of at least
two additional alleles. After further passage to CTVM St72,
one of these new alleles has become dominant, while the
original ILRI 3014 allele is indiscernible. This genotypic
proﬁlewas retained after an additional passage of the stock
to yield CTVM St96. Multi locus genotyping (MLG) of
clones obtained from CTVM St72 and St96 with a panel of
69 satellite markers, as well as 5 PCR size polymorphisms
and 3 PCR-RFLPs, conﬁrmed that both stabilates are
dominated by the same genotype (72-01). Of 287 clones
obtained from stabilate CTVM St72, 218 (76%) carried the
72-01 genotype, while most of the remaining 69 clones
were singletons. Similarly, the 72-01 genotype accounted
for 76.2% of clones analysed from CTVM 96 and the
frequency of 72-01 alleles carried by the remainder was
higher than that observed in CTVM St72.
3.3. Evidence of immune selection
The impact of the bovine immune response on the
progression of T. parva infection was studied by challen-
ging a calf immunised against the 72-01 genotype with the
parent stabilate CTVM St72. The immune status of the calf
was conﬁrmed prior to challenge by detection of parasite-
speciﬁc CTL in vitro. The animal developed mild clinical
signs following challenge, with transient fever and
emergence of both schizonts and piroplasms, and recov-
ered without treatment. Ticks fed on the animal following
challenge exhibited low infection rates but were used to
generate a working stabilate, CTVM St105. Parasite clones
were obtained from lymph node aspirates collected on
days 9 (n = 34) and 14 (n = 27) of the challenge infection
and from cloned parasitized cell lines derived by in vitro
infection with CTVM St105 (n = 75). MLG analysis of the ex
vivo-derived clones with a subset of 69 polymorphic
markers, including 5 genes with PCR size polymorphisms,
revealed only 7 occurrences of the 72-01 genotype at day 9.
The genotypewas not detected among the day 14 clones or
those generated in vitro using the CTVM St105 stabilate. A
signiﬁcant reduction in the prevalence of the 72-01
genotype was also apparent in DNA ampliﬁed from serial
lymphnode aspirates and erythrocyte theileriosis fractions
collected during the challenge infection. This is illustrated
in Fig. 4 using the polymorphic marker MS27, which is
representative of several markers for both non-coding and
coding regions (Fig. 4). In addition, the 72-10 alleles of four
expressed genes (TP01-0966, TP01-1233, TP03-0681,
TP04-0051) were absent from over 82% of the parasite
clones analysed from the breakthrough stabilate CTVM-
St105 (data not shown).
4. Discussion
We describe an expanded set of molecular markers for
the study of population diversity in T. parva parasites. The
panel now comprises 141 PCR based markers that are
distributed across the genome as depicted in Fig. 2, which
shows revised position for previously published satellite
markers on chromosome 3 (Oura et al., 2003). The markers
are not evenly distributed, but instead often cluster
together in certain regions of the four chromosomes.
Attempts to identify markers in gaps have met with only
limited success, suggesting that the regions that lack
polymorphic markers may represent regions in which the
T. parva genome is conserved across different isolates.
Alternatively, they may simply reﬂect conservation
between the Muguga and Marikebuni isolates in these
regions of the genome. It is therefore possible that testing
markers that failed to reveal polymorphisms in this study
might do so if tested on a broader range of isolates. This
might reveal more markers for chromosome 4 and provide
a sufﬁcient marker density to support an approach for
strain speciﬁc antigen identiﬁcation similar to that
adopted by Martinelli et al. (2005) in their genetic
Fig. 3. Satellite analysis of whole genomic DNA extracted from four
successive generations of the T. parva Marikebuni isolate using marker
MS14. Lane 1, ILRI St3014; lane 2, CTVM St70; lane 3, CTVM St72; lane 4,
CTVM St96. The arrows mark amplicon sizes in base pairs.
Fig. 4. Clearance of the immunising parasite genotype 72-01 in lymph
node and erythrocyte compartments on the indicated days after challenge
with stabilate CTVM St72 as revealed by PCR ampliﬁcation with satellite
marker MS27. The arrowheads denote the allele carried by the
immunising genotype 72-01. The arrows mark amplicon sizes in base
pairs.
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approach to mapping targets of strain speciﬁc immunity in
malaria.
These genetic tools have allowed us to evaluate parasite
diversity in both distinct and related T. parva stabilates.
Analysis of the T. parva Muguga stabilate CTVM St80 has
shown that the stabilate is almost clonal (data not shown);
out of 48 clones analysed 45 were identical and only 4
multi locus genotypes were observed. These were dis-
tinguished by differences at only 3 satellite loci. In the case
of one locus, one of the observed alleles was novel, while
the other 2 had been seen before inMarikebuni clones. The
novel allele may have arisen through spontaneous muta-
tion within the Muguga stabilate. Alternatively, this and
the other 2 alleles may reﬂect true diversity that has
survived many cattle to tick passages and remain the only
examples of polymorphism left from the original Muguga
isolate.
The observation of a total of 70 genotypes within the
CTVMSt72was surprising as analysis of bulk stabilate DNA
with individual markers suggested the presence of a
dominant genotype along with, possibly, one or two
others. This level of diversity, coupled with the substantial
changes observed after a single cattle–tick passage, has
important implications for the design of experiments that
rely on T. parva stabilates. Workers in the past have
assumed that the genetic composition of heterogeneous
stabilates is relatively stable.
This has important implications for maintenance of
the ‘‘Muguga cocktail’’, which forms the basis of
infection and treatment immunisation in eastern Africa.
Comprising three heterogeneous stocks – Muguga,
Kiambu 5 and Serengeti transformed – there is clearly
a danger that repeated passage will result in changes in
the antigenic composition of the cocktail. The molecular
typing reagents described in this paper provide a
valuable tool to characterise the individual components
of the ‘‘Muguga cocktail’’ and, possibly, to identify which
genotype or genotype-combinations are essential to
confer protection against natural ﬁeld challenge. The
identiﬁcation of the protective components will be
essential for quality assurance of the next generation
of the ‘‘Muguga cocktail’’.
The underlying cause of the observed changes in
parasite composition of successive T. parva Marikebuni
stabilates remains unclear. The history of these stabilates
has shown that three tick lines were used to propagate the
parasite during the course of these passages, which
occurred at ILRI, NVRC Muguga and the CTVM. Hence,
ILRI ticks were used to generate ILRI St3014, CTVM St70
arose from the tick colony at the NVRC and CTVM St72 and
St96 were generated with ticks from the CTVM colony.
Another possible reason for these changes is that distinct
cattle breeds were used at each stage—Boran cattle were
used at ILRI, the NVRC used a Boran-Friesian cross and
Friesian calves were used at the CTVM. Alternatively, the
emergence of dominant genotypes or changes of genotype
composition may simply be stochastic, representing a
chance event in which a given parasite genotype manages
to establish initially a more vigorous infection in the
bovine host and thereby subsequently dominates the
infection in the tick host.
Immunisation with the 72-01 genotype followed by
challenge with CTVM St72, in which the 72-01 genotype
accounts for 76% of the parasite population, has shown that
while the bovine immune response can clear the immu-
nising parasite genotype during the challenge infection,
other genotypes can persist and be transmitted to feeding
ticks. This is in line with the reported tight focus of the CTL
response (see McKeever, 2006). This has very important
implications for the sustained use of a given infection and
treatment vaccine in the same geographical area. It may
lead to the selection of local parasite strains, which are
antigenicly distinct from the vaccine components, which,
in time would result in failure of the vaccine.
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